Headache News and Research

Latest Headache News and Research

Study evaluates transcutaneous vagus nerve stimulation as treatment for long COVID-chronic fatigue

In a recent study posted to the medRxiv* server, researchers evaluated non-invasive transcutaneous vagus nerve stimulation [tVNS] as a treatment for long COVID-related chronic fatigue syndrome (CFS).

10 Nov 2022

People of all age groups are at risk of post-COVID-19 syndrome, study says

Following COVID-19 infection, there is significant new onset morbidity in children, adolescents and adults across 13 distinct diagnosis and symptom complexes, according to a new study publishing November 10th in the open access journal PLOS Medicine by Martin Roessler of Technische Universität Dresden, Germany, and colleagues.

10 Nov 2022

Nurses exposed to high levels of noise more likely to report health problems

Health care isn’t traditionally considered a “loud” occupation, so while many studies have examined the poor outcomes associated with hospitalized patients’ noise exposure, few look at health care workers’ noise exposure.

10 Nov 2022

The spectrum of SARS-CoV-2–related neurologic involvement among children and adolescents in 2021

Researchers explored the distribution of severe neurologic involvement in SARS-CoV-2 pediatric patients.

10 Nov 2022

Major life stressors may worsen long COVID symptoms

The death of a loved one, financial or food insecurity, or a newly developed disability were some of the strongest predictors of whether a patient hospitalized for COVID-19 would experience symptoms of long COVID a year later, a new study finds.

9 Nov 2022

Pioneering research identifies a promising treatment approach for myelofibrosis

Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.

9 Nov 2022

What are the eye complications associated with monkeypox infection?

A new study describes the association between monkeypox infection and eye complications in humans.

9 Nov 2022

Vaccinations against COVID-19 lead to higher antibody concentrations in persons with vaccine reactions

After the second and third vaccinations against COVID-19, a significantly higher antibody concentration has been confirmed, while tolerability was good.

4 Nov 2022

Extensive European study finds very high rates of long-COVID

In a recent study published by the European Center for Disease Prevention and Control, researchers assessed the prevalence of post-coronavirus disease 2019 (COVID-19) condition symptoms.

1 Nov 2022

Exploring the safety and immunogenicity of KD-414, a novel SARS-CoV-2 vaccine

In a new study, researchers assessed the immunogenicity and safety of KD-414, an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.

1 Nov 2022

The serial interval and incubation period for symptom and rash onset for monkeypox virus infection during the current US outbreak

Researchers estimated the serial interval and incubation period of monkeypox virus (MPXV) infections for the 2022 disease outbreak in the United States (US).

1 Nov 2022

Cohort study determines how often COVID-19 symptoms recurred

Researchers at University of California San Diego School of Medicine, with colleagues from the ACTIV-2 trial, part of the U.S. government's response to COVID-19, investigated whether symptoms of COVID-19 recurred following a two-day symptom-free period in persons who did not receive any treatment for the disease.

1 Nov 2022

When monkeypox reaches rural communities, it collides with strained public health systems

When a case of monkeypox was reported in Nevada's Humboldt County in August, it was the state's first detected occurrence of the virus in a rural area. Soon, cases were found in other rural counties — Nye, Lyon, and Elko — posing another hurdle for public health systems that have been worn thin by the covid-19 pandemic.

28 Oct 2022

Long COVID, a new clinical entity constantly evolving

Researchers discuss the epidemiology, diagnosis, pathogenesis, and treatment of long COVID.

27 Oct 2022

What is the association of self-reported post-vaccination symptoms with anti–SARS-CoV-2 antibody response?

Researchers investigated the association of symptoms after COVID-19 vaccination with antibody responses against SARS-CoV-2.

26 Oct 2022

Danish study shows 3rd booster dose reduces risk of long-COVID

A recent study posted to the medRxiv* preprint server found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the Omicron variant predominant period was associated with post-acute symptoms of coronavirus disease 2019 (COVID-19) or ‘long COVID’, as well general health problems with new onset – four months after a COVID-19 positive test result.

17 Oct 2022

Inhalation therapeutics against COVID-19

A recent study published in the Pulmonary Pharmacology & Therapeutics journal described different inhalation therapeutic agents for treating respiratory viral infections like coronavirus disease 2019 (COVID-19).

17 Oct 2022

Review on Panax ginseng therapeutic efficacy for COVID-19-associated neurological diseases

In a new study, researchers discussed the therapeutic potential of Panax ginseng for COVID-19 (coronavirus disease 2019)-induced neurological diseases.

14 Oct 2022

COVID-19 vaccination reduced the severity of the Omicron-driven pandemic wave in Saudi Arabia

In a new study, researchers conducted a retrospective study of all COVID-19 cases from a single hospital in the Kingdom of Saudi Arabia (KSA) between December 25, 2021, and February 30, 2022.

14 Oct 2022

Will covid spike again this fall? 6 tips to help you stay safe

Last year, the emergence of the highly transmissible omicron variant of the covid-19 virus caught many people by surprise and led to a surge in cases that overwhelmed hospitals and drove up fatalities. Now we're learning that omicron is mutating to better evade the immune system.

14 Oct 2022

Headache News and Research

Latest Headache News and Research

Study evaluates transcutaneous vagus nerve stimulation as treatment for long COVID-chronic fatigue

People of all age groups are at risk of post-COVID-19 syndrome, study says

Nurses exposed to high levels of noise more likely to report health problems

The spectrum of SARS-CoV-2–related neurologic involvement among children and adolescents in 2021

Major life stressors may worsen long COVID symptoms

Pioneering research identifies a promising treatment approach for myelofibrosis

What are the eye complications associated with monkeypox infection?

Vaccinations against COVID-19 lead to higher antibody concentrations in persons with vaccine reactions

Extensive European study finds very high rates of long-COVID

Exploring the safety and immunogenicity of KD-414, a novel SARS-CoV-2 vaccine

The serial interval and incubation period for symptom and rash onset for monkeypox virus infection during the current US outbreak

Cohort study determines how often COVID-19 symptoms recurred

When monkeypox reaches rural communities, it collides with strained public health systems

Long COVID, a new clinical entity constantly evolving

What is the association of self-reported post-vaccination symptoms with anti–SARS-CoV-2 antibody response?

Danish study shows 3rd booster dose reduces risk of long-COVID

Inhalation therapeutics against COVID-19

Review on Panax ginseng therapeutic efficacy for COVID-19-associated neurological diseases

COVID-19 vaccination reduced the severity of the Omicron-driven pandemic wave in Saudi Arabia

Will covid spike again this fall? 6 tips to help you stay safe

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Headache News and Research

Latest Headache News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in